Latest News

Date Title Topic
11 May 2013 EMCTO 2013 News: Stereotactic ablative radiotherapy is an effective alternative in patients with multiple primary lung cancers Lung and other thoracic tumours
10 May 2013 EMCTO News: Evaluation of performance of lung cancer screening strategy in the first three rounds of the NELSON trial Cancer prevention - Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: Different survival outcome following diagnosis of metastatic bone disease shown for EGFR mutated NSCLC patients in small retrospective study Translational research - Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: A study of simultaneous occurrence of EGFR mutations and HER2 gene amplifications in large series of NSCLC Translational research - Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: Meta-analysis slightly favours platinum-based first-line treatment in patients with advanced/metastatic NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 May 2013 EMCTO 2013 News: First-line gefitinib effective and well tolerated in Caucasian patients with EGFR mutation-positive NSCLC Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
10 May 2013 EMCTO 2013 News: Findings support the value of tumour rebiopsy in NSCLC patients Lung and other thoracic tumours
10 May 2013 EMCTO 2013 News: Enobosarm improves muscle wasting experienced by patients with NSCLC Palliative and supportive care - Lung and other thoracic tumours
06 May 2013 Clinical Research in HER2 Positive Metastatic Breast Cancer – Ethical Issues of Trials Conducted in Low Resource Environments Breast cancer
03 May 2013 IMPAKT 2013 Press Release: Genetic and clinical factors best for predicting late recurrence in oestrogen receptor positive breast cancer Breast cancer - Personalised medicine
03 May 2013 IMPAKT 2013 Press Release: Study Opens New Prospects for Developing Dew Targeted Therapies for Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
03 May 2013 IMPAKT 2013 Press Release: Study confirms Everolimus can overcome Trastuzumab resistance in IN HER-2 positive early breast cancer Breast cancer - Anticancer agents & Biologic therapy
03 May 2013 IMPAKT 2013 Press Release: Gene Expression Test Distinguishes Between Breast Cancer Patients at High and Low Risk of Late Recurrence Breast cancer - Personalised medicine
02 May 2013 IMPAKT 2013 Press Release: Study reveals magnitude of variation in gene expression measurements within breast cancers Breast cancer - Pathology/Molecular biology - Personalised medicine
02 May 2013 IMPAKT 2013 Press Release: Breast cancer heterogeneity no barrier to predictive testing, study shows Breast cancer - Personalised medicine